CYTOMEGALOVIRUS PROPHYLAXIS

Clinical trials for CYTOMEGALOVIRUS PROPHYLAXIS explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS PROPHYLAXIS trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First test of virus shield for tiny transplant patients

Prevention Recruiting now

This study is testing a drug called letermovir to prevent cytomegalovirus (CMV) infection in children and teens who have received a kidney transplant and weigh less than 88 pounds. Researchers want to understand how the child's body processes the drug and check if it is safe and …

Matched conditions: CYTOMEGALOVIRUS PROPHYLAXIS

Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention

Last updated Mar 31, 2026 12:11 UTC

CYTOMEGALOVIRUS PROPHYLAXIS

Get alerted when new CYTOMEGALOVIRUS PROPHYLAXIS trials appear

First test of virus shield for tiny transplant patients